Article
Phenotypic screening: the future of antibody discovery.
Drug discovery today - 1 Jan 2016
Gonzalez-Munoz Andrea L, Minter Ralph R, Rust Steven J
Abstract excerpt
Most antibody therapeutics have been isolated from high throughput target-based screening. However, as the number of validated targets diminishes and the target space becomes increasingly competitive, alternative strategies, such as phenotypic screening, are gaining momentum. Here, we review successful phenotypic screens, including those used to isolate antibodies against cancer and infectious agents. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
